Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora M Hagelberg

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
European Journal of Clinical Pharmacology|September 1, 2018
Voriconazole greatly increases the exposure to oral buprenorphineMari Fihlman, Tuija Hemmilä, Nora M Hagelberg, et al.
European Journal of Clinical Pharmacology|August 12, 2016
Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interactionMari Fihlman, Tuija Hemmilä, Nora M Hagelberg, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
European Journal of Clinical Pharmacology|September 1, 2018
Voriconazole greatly increases the exposure to oral buprenorphineMari Fihlman, Tuija Hemmilä, Nora M Hagelberg, et al.
European Journal of Clinical Pharmacology|August 12, 2016
Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interactionMari Fihlman, Tuija Hemmilä, Nora M Hagelberg, et al.
Pageof 3